Search

Search Constraints

You searched for: Author/Creator Lowy, Douglas R.

Search Results

1. Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins. Issue 7 (1st December 2017)

4. Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. (28th August 2017)

5. Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies. Issue 32 (6th August 2018)

7. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial. Issue 7 (July 2022)

8. Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial. Issue 1 (3rd January 2022)

9. Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. (September 2020)